Cargando…
Structure‐Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits
Proteasomes are established therapeutic targets for hematological cancers and promising targets for autoimmune diseases. In the past, we have designed and synthesized mechanism‐based proteasome inhibitors that are selective for the individual catalytic activities of human constitutive proteasomes an...
Autores principales: | Maurits, Elmer, Degeling, Christian G., Kisselev, Alexei F., Florea, Bogdan I., Overkleeft, Herman S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754458/ https://www.ncbi.nlm.nih.gov/pubmed/32598532 http://dx.doi.org/10.1002/cbic.202000375 |
Ejemplares similares
-
Structure-Based
Design of Inhibitors Selective for
Human Proteasome β2c or β2i Subunits
por: Xin, Bo-Tao, et al.
Publicado: (2019) -
The ATP/Mg(2+) Balance Affects the Degradation of Short Fluorogenic Substrates by the 20S Proteasome
por: Morozov, Alexey, et al.
Publicado: (2022) -
Assessing Subunit Dependency of the Plasmodium Proteasome Using Small Molecule Inhibitors and Active Site Probes
por: Li, Hao, et al.
Publicado: (2014) -
Development of a DUB-selective fluorogenic substrate
por: Gjonaj, Lorina, et al.
Publicado: (2019) -
Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates
por: Kim, Sumin, et al.
Publicado: (2022)